# The impact of COVID-19 on GiveWell’s plans

We hope everyone is staying well during these difficult times. We are publishing this blog post to provide a brief update on how the COVID-19 (coronavirus) pandemic impacts our plans.

We are looking into the impact of the pandemic on the organizations we support as well as opportunities to mitigate its effects. We are in the early stages of this work and will update you as we reach conclusions.

We don’t have a new recommendation for donors: our bottom line continues to be to donate to “Grants to recommended charities at GiveWell’s discretion,” which we allocate quarterly to the highest priority need we see.

# Allocation of discretionary funds from Q4 2019

We recently allocated donations made from October through December 2019 to “Grants to recommended charities at GiveWell’s discretion.” We granted $11.9 million to Malaria Consortium’s seasonal malaria chemoprevention program and$1.5 million to Helen Keller International’s vitamin A supplementation program.

We allocate donations to “Grants to recommended charities at GiveWell’s discretion” (discretionary funds) quarterly, according to where we see the highest-priority funding needs. Malaria Consortium’s seasonal malaria chemoprevention (SMC) program and Helen Keller International (HKI)’s vitamin A supplementation (VAS) program had the top-priority needs among our top charities at the time we made this decision.

Malaria Consortium provides preventive anti-malarial medication to young children during the time of year when malaria transmission is highest. HKI supports provision of vitamin A supplements to young children, which reduces their risk of dying of infectious disease.[1] We estimate that the combined discretionary grants to these organizations will save 5,600 lives.[2]

In this post, we discuss:

• Our process for deciding where to allocate discretionary funds. (More)
• We share updates on:
• HKI’s VAS program. (More)
• Malaria Consortium’s SMC program. (More)
• SCI Foundation. (More)
• We also discuss uncertainties in our decision. (More)
• Our bottom line for donors giving today. (More)